These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31668797)

  • 21. Piperazine and piperidine carboxamides and carbamates as inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
    Korhonen J; Kuusisto A; van Bruchem J; Patel JZ; Laitinen T; Navia-Paldanius D; Laitinen JT; Savinainen JR; Parkkari T; Nevalainen TJ
    Bioorg Med Chem; 2014 Dec; 22(23):6694-6705. PubMed ID: 25282655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of Monoacylglycerol Lipase (MAGL) Inhibitors Based on a Pharmacophore-Guided Virtual Screening Study.
    Jha V; Biagi M; Spinelli V; Di Stefano M; Macchia M; Minutolo F; Granchi C; Poli G; Tuccinardi T
    Molecules; 2020 Dec; 26(1):. PubMed ID: 33375358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 4-Aryliden-2-methyloxazol-5(4H)-one as a new scaffold for selective reversible MAGL inhibitors.
    Granchi C; Rizzolio F; Bordoni V; Caligiuri I; Manera C; Macchia M; Minutolo F; Martinelli A; Giordano A; Tuccinardi T
    J Enzyme Inhib Med Chem; 2016; 31(1):137-46. PubMed ID: 25669350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis, molecular modelling and in vitro cytotoxicity analysis of novel carbamate derivatives as inhibitors of Monoacylglycerol lipase.
    Lauria S; Perrotta C; Casati S; Di Renzo I; Ottria R; Eberini I; Palazzolo L; Parravicini C; Ciuffreda P
    Bioorg Med Chem; 2018 May; 26(9):2561-2572. PubMed ID: 29678535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoacylglycerol lipase (MAGL) inhibitors based on a diphenylsulfide-benzoylpiperidine scaffold.
    Bononi G; Tonarini G; Poli G; Barravecchia I; Caligiuri I; Macchia M; Rizzolio F; Demontis GC; Minutolo F; Granchi C; Tuccinardi T
    Eur J Med Chem; 2021 Nov; 223():113679. PubMed ID: 34218085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1,3,4-Oxadiazol-2-ones as fatty-acid amide hydrolase and monoacylglycerol lipase inhibitors: Synthesis, in vitro evaluation and insight into potency and selectivity determinants by molecular modelling.
    Käsnänen H; Minkkilä A; Taupila S; Patel JZ; Parkkari T; Lahtela-Kakkonen M; Saario SM; Nevalainen T; Poso A
    Eur J Pharm Sci; 2013 Jun; 49(3):423-33. PubMed ID: 23557840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The discovery of diazetidinyl diamides as potent and reversible inhibitors of monoacylglycerol lipase (MAGL).
    Zhu B; Connolly PJ; Zhang SP; Chevalier KM; Milligan CM; Flores CM; Macielag MJ
    Bioorg Med Chem Lett; 2020 Jun; 30(12):127198. PubMed ID: 32334914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and Synthesis of Novel Spiro Derivatives as Potent and Reversible Monoacylglycerol Lipase (MAGL) Inhibitors: Bioisosteric Transformation from 3-Oxo-3,4-dihydro-2
    Ikeda S; Sugiyama H; Tokuhara H; Murakami M; Nakamura M; Oguro Y; Aida J; Morishita N; Sogabe S; Dougan DR; Gay SC; Qin L; Arimura N; Takahashi Y; Sasaki M; Kamada Y; Aoyama K; Kimoto K; Kamata M
    J Med Chem; 2021 Aug; 64(15):11014-11044. PubMed ID: 34328319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Set-Up and Validation of a High Throughput Screening Method for Human Monoacylglycerol Lipase (MAGL) Based on a New Red Fluorescent Probe.
    Miceli M; Casati S; Ottria R; Di Leo S; Eberini I; Palazzolo L; Parravicini C; Ciuffreda P
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31208066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting Monoacylglycerol Lipase in Pursuit of Therapies for Neurological and Neurodegenerative Diseases.
    Zanfirescu A; Ungurianu A; Mihai DP; Radulescu D; Nitulescu GM
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The discovery of azetidine-piperazine di-amides as potent, selective and reversible monoacylglycerol lipase (MAGL) inhibitors.
    Zhu B; Connolly PJ; Zhang YM; McDonnell ME; Bian H; Lin SC; Liu L; Zhang SP; Chevalier KM; Brandt MR; Milligan CM; Flores CM; Macielag MJ
    Bioorg Med Chem Lett; 2020 Jul; 30(14):127243. PubMed ID: 32527545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. beta-Lactams derived from a carbapenem chiron are selective inhibitors of human fatty acid amide hydrolase versus human monoacylglycerol lipase.
    Feledziak M; Michaux C; Urbach A; Labar G; Muccioli GG; Lambert DM; Marchand-Brynaert J
    J Med Chem; 2009 Nov; 52(22):7054-68. PubMed ID: 19877691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitors.
    Granchi C; Caligiuri I; Bertelli E; Poli G; Rizzolio F; Macchia M; Martinelli A; Minutolo F; Tuccinardi T
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1240-1252. PubMed ID: 28936880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of long-chain salicylketoxime derivatives as monoacylglycerol lipase (MAGL) inhibitors.
    Bononi G; Granchi C; Lapillo M; Giannotti M; Nieri D; Fortunato S; Boustani ME; Caligiuri I; Poli G; Carlson KE; Kim SH; Macchia M; Martinelli A; Rizzolio F; Chicca A; Katzenellenbogen JA; Minutolo F; Tuccinardi T
    Eur J Med Chem; 2018 Sep; 157():817-836. PubMed ID: 30144699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-Activity Relationship Studies of Aryl Sulfoxides as Reversible Monoacylglycerol Lipase Inhibitors.
    Jiang M; Huizenga MCW; Mohr F; Amedi A; Bakker R; van den Berg RJBHN; Deng H; van der Wel T; van Boeckel CAA; van der Stelt M
    J Med Chem; 2024 Jul; 67(14):12331-12348. PubMed ID: 38988250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and characterization of endocannabinoid hydrolases FAAH and MAGL inhibitors bearing a benzotriazol-1-yl carboxamide scaffold.
    Morera L; Labar G; Ortar G; Lambert DM
    Bioorg Med Chem; 2012 Nov; 20(21):6260-75. PubMed ID: 23036333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New diterpenes from Salvia pseudorosmarinus and their activity as inhibitors of monoacylglycerol lipase (MAGL).
    De Leo M; Huallpa CG; Alvarado B; Granchi C; Poli G; De Tommasi N; Braca A
    Fitoterapia; 2018 Oct; 130():251-258. PubMed ID: 30240845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis and biological evaluation of second-generation benzoylpiperidine derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors.
    Granchi C; Bononi G; Ferrisi R; Gori E; Mantini G; Glasmacher S; Poli G; Palazzolo S; Caligiuri I; Rizzolio F; Canzonieri V; Perin T; Gertsch J; Sodi A; Giovannetti E; Macchia M; Minutolo F; Tuccinardi T; Chicca A
    Eur J Med Chem; 2021 Jan; 209():112857. PubMed ID: 33045662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiosynthesis and ex vivo evaluation of [(11)C-carbonyl]carbamate- and urea-based monoacylglycerol lipase inhibitors.
    Hicks JW; Parkes J; Tong J; Houle S; Vasdev N; Wilson AA
    Nucl Med Biol; 2014 Sep; 41(8):688-94. PubMed ID: 24969632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rational Development of MAGL Inhibitors.
    Granchi C; Rizzolio F; Caligiuri I; Macchia M; Martinelli A; Minutolo F; Tuccinardi T
    Methods Mol Biol; 2018; 1824():335-346. PubMed ID: 30039417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.